FDA approval of teprotumumab as therapeutic offers hope for patients.
Maximizing refractive surgery is key to ensuring prosperous future
John D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.
In a conversation with the Eye Care Network at ARVO, Osamah Saeedi, MD, MS, Associate Professor of Ophthalmology, Director of Clinical Research and Director of the Glaucoma Division at the University of Maryland School of Medicine, explained the key findings from his poster.
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
Minimizing clinic visits, maximizing use of imaging modalities are key.
Ophthalmologists end their discussion on the management of dry eye disease with other ocular comorbidities highlighting key takeaways and prospective advances in care and outcomes.
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
Systemic immunosuppression may prevent devastating complication in patients.
Ophthalmologists can reduce IOP and medications with endocyclophotocoagulation while in the eye.
Procedure can improve best-corrected visual acuity, enhancing quality of life for patients.
Need to eliminate errors results in optimization of training of novice surgeons.
Carl D. Regillo, MD, and Jennifer I. Lim, MD, emphasize the high regulatory standards of equivalence and safety of biosimilars in considering the role they will play in the evolving treatment landscape for retinal disorders.
Prompt and adequate action is a key to facilitating the best recovery in patients.
Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents.
Working as an investigator can prove to be a positive experience for physicians
A patient's vision loss leads to another diagnosis
The 18th annual Controversies in Modern Eye Care conference, held on May 4, 2024, in Los Angeles, was co-chaired by Neda Shamie, MD, and Arjan Hura, MD, with the aim of discussing the latest advancements in eye care.
Dilsher S. Dhoot, MD discusses a recent case-based roundtable meeting on anti-VEGF biosimilars, highlighting the first of two case discussions.
Dilsher S. Dhoot, MD, and A. Paul Chous, MA, OD, FAAO, discuss future directions and unmet needs in the field of retinal eye disease.
One obvious trend has been that dry eye disease is a concurrent problem for virtually all my patients, and we need to address it for optimum comfort and surgical results.
Look beyond isolated treatment of the eye to address systemic factors.
Treatment of patients with COVID-19 should include ophthalmic considerations.
Andrew Lee, MD, Andrew Carey, MD, and Elizabeth Fortin, MD, sit down on this episode of the NeuroOp Guru to discuss neuro-ophthalmology, interprofessional eConsults, and whether they provide timely and valuable guidance